Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter C. Enzinger, M.D.

Concepts (282)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Esophageal Neoplasms40202415835.120 Why?
Stomach Neoplasms30202413333.340 Why?
Esophagogastric Junction1720243132.700 Why?
Adenocarcinoma41202463642.260 Why?
Antineoplastic Combined Chemotherapy Protocols512024115241.770 Why?
Camptothecin1720175761.070 Why?
Cisplatin16202216621.070 Why?
Fluorouracil23202416191.050 Why?
Platinum120222330.770 Why?
Carcinoma, Squamous Cell10202340340.630 Why?
Neoadjuvant Therapy9202127280.600 Why?
Gastrointestinal Neoplasms720239900.580 Why?
Leucovorin1320226280.560 Why?
Clinical Protocols1202114620.500 Why?
Cyclooxygenase 2 Inhibitors120163200.480 Why?
Esophagectomy520214470.460 Why?
Gastrectomy320216630.430 Why?
Colonic Neoplasms8201725410.410 Why?
Neuroendocrine Tumors720225940.400 Why?
Antineoplastic Agents142020136950.390 Why?
Organoplatinum Compounds820194080.380 Why?
Pancreatic Neoplasms11202352560.350 Why?
Receptor, Fibroblast Growth Factor, Type 2320241880.310 Why?
Research Design2202159870.310 Why?
Paclitaxel7202317080.300 Why?
Colorectal Neoplasms14202367730.300 Why?
Aged6420231632800.260 Why?
Surgery Department, Hospital120071750.260 Why?
Aged, 80 and over392021577760.250 Why?
Disease-Free Survival12201768950.240 Why?
Carboplatin320228010.240 Why?
Neoplasm Staging162021110310.240 Why?
Epirubicin32021800.230 Why?
Survival Rate132021127880.230 Why?
Combined Modality Therapy10202186420.230 Why?
Middle Aged6320222133830.230 Why?
Taxoids320206660.230 Why?
Antineoplastic Agents, Phytogenic320066240.220 Why?
Deoxycytidine1020148260.220 Why?
Receptor, erbB-23202324160.210 Why?
Humans10320247443430.210 Why?
Male7120233501180.210 Why?
Hypoalbuminemia12023870.210 Why?
Drug Administration Schedule11201649330.210 Why?
Granuloma, Foreign-Body12021450.200 Why?
Adult5620212140550.200 Why?
Female7120233801940.200 Why?
Appendiceal Neoplasms120231460.200 Why?
Antibodies, Monoclonal10202392740.190 Why?
Anus Neoplasms320123320.190 Why?
Topoisomerase I Inhibitors12000650.190 Why?
Keratins120215150.180 Why?
Barrett Esophagus120044940.180 Why?
Quinazolines9201213560.170 Why?
Rectal Neoplasms3201512060.170 Why?
Colectomy120046830.170 Why?
Neoplasm Metastasis13201748510.170 Why?
Lymph Node Excision2202012610.170 Why?
Dacarbazine320125660.170 Why?
Liver Neoplasms6201442530.160 Why?
Neutropenia120238950.150 Why?
Peritoneal Neoplasms120236650.150 Why?
HSP90 Heat-Shock Proteins120204340.140 Why?
Maximum Tolerated Dose620128920.140 Why?
Deglutition Disorders320166050.140 Why?
Double-Blind Method52023120260.140 Why?
Quality-Adjusted Life Years1202216830.140 Why?
Administration, Oral6201639130.140 Why?
Vascular Endothelial Growth Factor Receptor-2120195460.140 Why?
Treatment Outcome302021631140.140 Why?
Anorexia120161610.130 Why?
Fluorodeoxyglucose F182201820160.130 Why?
Microsatellite Instability320226840.130 Why?
Neoplasms, Second Primary1202310610.130 Why?
Carcinoma2202023750.120 Why?
Lymphatic Metastasis2202129240.120 Why?
Medical Oncology5202322650.120 Why?
Survival Analysis132021102520.120 Why?
Guidelines as Topic2201914050.120 Why?
Alcohol Drinking2200439660.120 Why?
Radiopharmaceuticals2201826450.120 Why?
Triazoles120209110.120 Why?
Neoplasm Recurrence, Local4201792390.120 Why?
Sirolimus2201315640.110 Why?
Antimetabolites, Antineoplastic320066400.110 Why?
Nausea120166730.110 Why?
Claudins220231110.110 Why?
Laparoscopy1200421510.100 Why?
Indoles2201118390.100 Why?
Angiogenesis Inhibitors4201420380.100 Why?
Palliative Care4201734930.100 Why?
beta Karyopherins12011470.100 Why?
Chemotherapy, Adjuvant2202134790.100 Why?
Carcinoma, Hepatocellular3200922140.100 Why?
Vascular Endothelial Growth Factors120127720.090 Why?
Informed Consent120179950.090 Why?
Hydroxychloroquine120144120.090 Why?
Treatment Failure1201626180.090 Why?
Preoperative Care2201322500.090 Why?
Phenylurea Compounds120135280.090 Why?
Immunoconjugates120179010.090 Why?
Cost-Benefit Analysis1202253910.090 Why?
Enzyme Inhibitors1200037980.090 Why?
Disease Progression72017132840.090 Why?
O(6)-Methylguanine-DNA Methyltransferase12009850.080 Why?
Kaplan-Meier Estimate6202065380.080 Why?
Carcinoid Tumor220092350.080 Why?
Genomic Instability120126950.080 Why?
Quinolines120137320.080 Why?
Time Factors72021400750.080 Why?
Biliary Tract Neoplasms120091780.080 Why?
Tubulin120116950.080 Why?
Patient Participation1201714570.080 Why?
Follow-Up Studies52019390500.070 Why?
Patient Education as Topic1201722780.070 Why?
Oxonic Acid12006410.070 Why?
Tegafur12006490.070 Why?
Autophagy1201413000.070 Why?
Endostatins120061740.070 Why?
Digestive System Neoplasms12006870.070 Why?
Prognosis52019290630.070 Why?
Geriatric Assessment1201313720.060 Why?
TOR Serine-Threonine Kinases2201121090.060 Why?
Vinblastine120065020.060 Why?
Delivery of Health Care1202253190.060 Why?
Melanoma1202355100.060 Why?
Video-Assisted Surgery12004510.060 Why?
Recombinant Proteins3202366220.060 Why?
Esophageal Fistula12003640.060 Why?
Pheochromocytoma120063370.060 Why?
Terminally Ill120052380.060 Why?
Data Collection1201333410.060 Why?
Young Adult72020564300.060 Why?
Retrospective Studies92023774490.060 Why?
CpG Islands1200711720.050 Why?
Radiotherapy Dosage2202128790.050 Why?
Pyrroles1200911460.050 Why?
Gallbladder Neoplasms120041830.050 Why?
Hypertension1202284800.050 Why?
Boronic Acids120069650.050 Why?
Carcinoma, Neuroendocrine120063320.050 Why?
Cell Transformation, Neoplastic1201229420.050 Why?
Vascular Endothelial Growth Factor A3202235080.050 Why?
Quality Improvement1201737490.050 Why?
Proto-Oncogene Proteins B-raf3202320430.050 Why?
Protein Kinases1200816400.050 Why?
Survival120211630.050 Why?
Practice Guidelines as Topic3201572790.050 Why?
Salvage Therapy1200712750.050 Why?
Pyrazines1200612300.050 Why?
Pyrimidinones120233710.050 Why?
Albumins120235690.050 Why?
Granulocyte Colony-Stimulating Factor120236480.050 Why?
Adrenal Gland Neoplasms120067400.050 Why?
Dose-Response Relationship, Drug32009109430.040 Why?
Mitogen-Activated Protein Kinase Kinases120236480.040 Why?
Antibodies, Bispecific120221640.040 Why?
Edema120237890.040 Why?
Nutrition Surveys1200516600.040 Why?
Isotretinoin119991140.040 Why?
Pyridones120237120.040 Why?
Prospective Studies32018532880.040 Why?
Clinical Trials, Phase II as Topic120006290.040 Why?
Molecular Diagnostic Techniques120236020.040 Why?
DNA, Neoplasm1202317580.040 Why?
Positron-Emission Tomography2201262340.040 Why?
Infusions, Intravenous3200922740.040 Why?
Pamphlets12017750.040 Why?
Protein-Tyrosine Kinases1200624550.040 Why?
Gastroesophageal Reflux120037820.040 Why?
Clinical Trials as Topic2200479130.040 Why?
Risk Assessment52021233380.030 Why?
Leukocytes, Mononuclear1202318360.030 Why?
Gene Amplification1202010630.030 Why?
In Situ Hybridization, Fluorescence1202226490.030 Why?
Retreatment120176100.030 Why?
ras Proteins2201410600.030 Why?
Oxaloacetates1201460.030 Why?
Interferon-alpha119998950.030 Why?
Risk Factors52021722900.030 Why?
China1202022480.030 Why?
Drug Resistance, Neoplasm3202051720.030 Why?
Neoplasms22017216830.030 Why?
Antineoplastic Agents, Alkylating220096270.030 Why?
Feeding Behavior1200531880.030 Why?
DNA Methylation1200742860.030 Why?
Karnofsky Performance Status120131730.030 Why?
Quality of Life32023128040.030 Why?
Genomics2202357200.030 Why?
United States42020698720.030 Why?
Video Recording120179490.030 Why?
Clinical Competence1200746870.020 Why?
Blood Loss, Surgical120156620.020 Why?
GTP Phosphohydrolases120145090.020 Why?
Tumor Microenvironment1202335860.020 Why?
Thalidomide220068900.020 Why?
Perioperative Care1201810020.020 Why?
Protein Kinase Inhibitors2202355350.020 Why?
Patient Compliance1202126840.020 Why?
Core Binding Factor Alpha 2 Subunit120123450.020 Why?
Medicare1200765660.020 Why?
Oncogene Protein v-akt120081350.020 Why?
Microtubule-Associated Proteins1201410860.020 Why?
Drug Therapy, Combination1199864890.020 Why?
Proto-Oncogene Proteins2201445540.020 Why?
Length of Stay1202163090.020 Why?
Chemokine CXCL12120094640.020 Why?
Proto-Oncogene Proteins p21(ras)1201416920.020 Why?
Smoking1200389870.020 Why?
Molecular Targeted Therapy1201827270.020 Why?
Carcinoma, Islet Cell12006220.020 Why?
Demography1201116560.020 Why?
Upper Gastrointestinal Tract12006480.020 Why?
Digestive System Surgical Procedures120115760.020 Why?
Tocopherols12005430.020 Why?
Disease Management1201724590.020 Why?
Lymphocytes1201426170.020 Why?
Chromosome Aberrations1201218130.020 Why?
Incidence12003209470.020 Why?
Self Administration120063850.020 Why?
Feasibility Studies1201550780.020 Why?
Cluster Analysis1201227150.020 Why?
Mice, Inbred C57BL12023218270.020 Why?
Injections, Subcutaneous120066660.020 Why?
Cyclin-Dependent Kinase Inhibitor p27120053230.020 Why?
Pilot Projects1201883240.020 Why?
Cyclin-Dependent Kinase Inhibitor p21120053650.020 Why?
Radiotherapy1201115330.020 Why?
Biopsy, Needle1201016410.020 Why?
Gene Deletion1201227510.020 Why?
Continuity of Patient Care1201110490.020 Why?
Gene Expression Regulation, Neoplastic1202084280.010 Why?
Age Factors12021183700.010 Why?
Piperidines1201216020.010 Why?
Confidence Intervals1200929710.010 Why?
DNA Copy Number Variations1201219410.010 Why?
Massachusetts2200786630.010 Why?
Patient Readmission1201731140.010 Why?
Patient Selection1201542150.010 Why?
Animals320231687570.010 Why?
Carotenoids120056240.010 Why?
Nutrition Assessment120057230.010 Why?
Mice22023811830.010 Why?
Mutation22023297860.010 Why?
Radiography1201270230.010 Why?
Drug Combinations1200619590.010 Why?
Injections, Intravenous1200314200.010 Why?
Proteasome Endopeptidase Complex1200613380.010 Why?
Databases, Factual1201577290.010 Why?
Recurrence1201183400.010 Why?
Doxorubicin1200622340.010 Why?
Interleukin-61200932000.010 Why?
Guideline Adherence1201022660.010 Why?
Early Detection of Cancer1201330860.010 Why?
Tomography, X-Ray Computed22012201290.010 Why?
Vitamin D1201232230.010 Why?
Phosphatidylinositol 3-Kinases1200829380.010 Why?
Decision Making1201338870.010 Why?
Postoperative Complications12021152950.010 Why?
Breast Neoplasms12005208220.010 Why?
Fatty Acids1200518090.010 Why?
Membrane Proteins1201478800.010 Why?
Randomized Controlled Trials as Topic1201499590.010 Why?
Electronic Health Records1201444680.010 Why?
Signal Transduction22011234030.010 Why?
Proto-Oncogene Proteins c-akt1200525030.010 Why?
DNA Mutational Analysis1200541860.010 Why?
Stem Cells1200935670.010 Why?
Cell Line, Tumor12012166890.010 Why?
Tumor Suppressor Proteins1200528490.010 Why?
Proportional Hazards Models12009123540.010 Why?
Tumor Suppressor Protein p531200529480.010 Why?
Hospitalization12014102620.010 Why?
Base Sequence12005127970.010 Why?
Cell Cycle Proteins1200534620.010 Why?
Multivariate Analysis12005122450.010 Why?
Immunohistochemistry12005113660.010 Why?
Algorithms12011138810.010 Why?
Genetic Predisposition to Disease12012174460.010 Why?
Adolescent12019857810.010 Why?
Reproducibility of Results12005199050.000 Why?
Magnetic Resonance Imaging12009354210.000 Why?
Enzinger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (282)
Explore
_
Co-Authors (119)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.